Durvalumab Impact in the Treatment Strategy of Stage III Non-Small Cell Lung Cancer (NSCLC): An EORTC Young Investigator Lung Cancer Group Survey

被引：0
|
作者：
Levra, M. Giaj [1 ]
Benet, J. [1 ]
Hasan, B. [2 ]
Berghmans, T. [3 ]
Bruni, A. [4 ]
Dingemans, A. M. [5 ]
Levra, N. Giaj [6 ]
Edwards, J. [7 ]
Faivre-Finn, C. [8 ]
Girard, N. [9 ]
Gobbini, E. [1 ]
Greillier, L. [10 ]
Hendriks, L. [5 ]
Lantuejoul, S. [11 ]
Levy, A. [12 ]
Novello, S. [13 ]
O'Brien, M. [14 ]
Reck, M. [15 ]
Pochesci, A. [2 ]
Menis, J. [16 ]
Besse, B. [12 ]
机构：
[1] CHU Grenoble, La Tronche, France
[2] Eortc, Brussels, Belgium
[3] Inst Jules Bordet, Brussels, Belgium
[4] Univ Hosp Modena, Dept Oncol & Hematol, Modena, Italy
[5] Maastricht Univ, Med Ctr, Maastricht, Netherlands
[6] Irccs Sacro Cuore Don Calabria Hosp, Negrar, Radiotherapy Unit, Verona, Italy
[7] Northern Gen Hosp, Sheffield, S Yorkshire, England
[8] Christie Univ Manchester, Dept Radiotherapy Related Res, Manchester, Lancs, England
[9] Inst Curie, Paris, France
[10] Ap Marseille, Serv Oncol Multidisciplinaire & Innovat Therapeut, Marseille, France
[11] Ctr Leon Berard, Lyon, France
[12] Inst Gustave Roussy, Villejuif, France
[13] Univ Turin, Dept Oncol, San Luigi Gonzaga Hosp, Orbassano, Italy
[14] Royal Marsden, London, England
[15] Lungen Clin, Grosshansdorf, Germany
[16] Iov, Padua, Italy
来源：
JOURNAL OF THORACIC ONCOLOGY | 2019年 / 14卷 / 10期
关键词：
durvalumab; stage III NSCLC; treatment strategy;
D O I：
10.1016/j.jtho.2019.08.557
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
MA08.02
引用
收藏
页码：S277 / S278
页数：2
相关论文
共 50 条
  • [41] Preoperative treatment strategies in stage III non-small cell lung cancer
    Eberhardt, W
    Bildat, S
    Korfee, S
    Stamatis, G
    [J]. LUNG CANCER, 2001, 33 : S51 - S59
  • [42] Induction treatment in patients with stage III non-small cell lung cancer
    Palmero, Ramon
    Vilarino, Noelia
    Navarro-Martin, Arturo
    Nadal, Ernest
    [J]. TRANSLATIONAL LUNG CANCER RESEARCH, 2021, 10 (01) : 539 - 554
  • [43] Chemoradiation for stage III non-small cell lung cancer
    Ramella, Sara
    Fiore, Michele
    Iurato, Aurelia
    Trodella, Luca E.
    Trodella, Lucio
    D'Angelillo, Rolando M.
    [J]. EUROPEAN JOURNAL OF ONCOLOGY, 2013, 18 (01): : 5 - 13
  • [44] TIME TO TREATMENT IN PATIENTS WITH STAGE III NON-SMALL CELL LUNG CANCER
    Wang, Li
    Correa, Candace R.
    Hayman, James A.
    Zhao, Lujun
    Cease, Kemp
    Brenner, Dean
    Arenberg, Doug
    Curtis, Jeffery
    Kalemkerian, Gregory P.
    Kong, Feng-Ming
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2009, 74 (03): : 790 - 795
  • [45] Management of stage III non-small cell lung cancer
    Tabchi, Samer
    Kassouf, Elie
    El Rassy, Elie
    Kourie, Hampig Raphael
    Martin, Jocelyne
    Campeau, Marie-Pierre
    Tehfe, Mustapha
    Blais, Normand
    [J]. SEMINARS IN ONCOLOGY, 2017, 44 (03) : 163 - 177
  • [46] Durvalumab Outcomes in Stage III Non-small Cell Lung Cancer: A Single-institution Study
    Trinh, Jonathan Q.
    Xiong, Ying
    Smith, Lynette M.
    Abughanimeh, Omar
    Marr, Alissa S.
    Ganti, Apar K.
    [J]. ANTICANCER RESEARCH, 2024, 44 (02) : 605 - 612
  • [47] International Cost-Effectiveness Analysis of Durvalumab in Stage III Non-Small Cell Lung Cancer
    Kareff, Samuel A.
    Han, Sunwoo
    Haaland, Benjamin
    Jani, Chinmay J.
    Kohli, Rhea
    Aguiar Jr, Pedro Nazareth
    Huang, Yiqing
    Soo, Ross A.
    Rodriguez-Perez, Angel
    Garcia-Foncillas, Jesus
    Domine, Manuel
    de Lima Lopes, Gilberto
    [J]. JAMA NETWORK OPEN, 2024, 7 (05)
  • [48] Timing of Adjuvant Durvalumab Initiation Is Not Associated With Outcomes in Stage III Non-small Cell Lung Cancer
    Bryant, Alex K.
    Sankar, Kamya
    Strohbehn, Garth W.
    Zhao, Lili
    Elliott, David
    Daniel, Victoria
    Ramnath, Nithya
    Green, Michael D.
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2022, 113 (01): : 60 - 65
  • [49] GENOMIC DETERMINANTS OF RESPONSE TO CHEMORADIATION AND DURVALUMAB CONSOLIDATION FOR STAGE III NON-SMALL CELL LUNG CANCER
    Guo, Matthew
    Murray, Joseph
    Ghanem, Paola
    Voong, Khinh Ranh
    Hales, Russell
    Feliciano, Josephine
    Marrone, Kristen
    [J]. JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2021, 9 : A263 - A263
  • [50] CONCURRENT CHEMORADIATION (CCHRT) FOR STAGE III NON-SMALL CELL LUNG CANCER (NSCLC): A PHASE II STUDY FROM THE GALICIAN LUNG CANCER GROUP
    Casal, Joaquin
    Ponte, C.
    Senin, C.
    Campos, B.
    Firvida, Xl
    Carmona, M.
    Hernandez, E.
    Lopez, Md
    Formoso, I.
    Lazaro, M.
    Vazquez, S.
    Areses, Mc
    Rodriguez, C.
    Pena, C.
    Villanueva, Mj
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2013, 8 : S849 - S849
12345